Forget the glorious successes of past breakthroughs—the real justification for research investment is what we get for our ...

The members voted against the combination shot for measles, mumps, rubella and chickenpox. Guidelines on vaccines given ...

First combination therapy to report 29.5 months of Median Overall Survival (mOS); Standard of care Keytruda® (pembrolizumab) alone (10.8 months) and Keytruda® + chemotherapy (12.3 months) in patients ...

Zapier reports that AI automation enhances traditional automation by combining intelligent technologies, improving efficiency ...

As we reported he would be yesterday, John Squires today was officially confirmed by the U.S. Senate to be the next Under ...

Read the latest analysis on ImmunityBio stock: strong Anktiva NMIBC data but slow sales and valuation concerns.

The detailed results from the HARMONi trial—the first global phase 3 data set for the world’s first PD-1xVEGF bispecific, ...

ProKidney shows strong Phase 2 CKD data, FDA support, and cash runway, with key readouts ahead despite single-asset risks.

Since Kennedy took over the U.S. Department of Health and Human Services, there’s been a lot of worry about just where a ...

This paper provides evidence that rising misallocation in the R&D sector contributed to the recent slowdown in U.S. productivity growth. I develop a growth accounting framework allowing for ...

"The iPhone Air is Apple's thinnest phone ever and its boldest design move since the iPhone X," Popal said. "It will draw in ...